Last $15.69 USD
Change Today -0.22 / -1.38%
Volume 216.9K
AMED On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 07/9/14 All times are local (Market data is delayed by at least 15 minutes).

amedisys inc (AMED) Snapshot

Open
$16.07
Previous Close
$15.91
Day High
$16.07
Day Low
$15.69
52 Week High
08/9/13 - $18.70
52 Week Low
07/23/13 - $10.76
Market Cap
514.8M
Average Volume 10 Days
1.0M
EPS TTM
$-0.23
Shares Outstanding
32.8M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for AMEDISYS INC (AMED)

amedisys inc (AMED) Related Businessweek News

View More BusinessWeek News

amedisys inc (AMED) Details

Amedisys Inc. provides home health and hospice services including practical nursing services and physical and occupational therapy. The company’s services also comprise speech pathology, social work to help families address acute and chronic illnesses, home health aide services, and private duty services. Hospice services use a team made up of a physician, patient care manager, registered nurses, certified home health aides, social workers, a chaplain, a homemaker, and volunteers. As of Apr. 4, 2007, the company operated 261 Medicare-certified home health agencies and 14 Medicare-certified hospice agencies in 19 states. Amedisys was founded in 1982 and is headquartered in Baton Rouge, La.

14,300 Employees
Last Reported Date: 03/12/14
Founded in 1982

amedisys inc (AMED) Top Compensated Officers

Interim Chief Executive Officer, President an...
Total Annual Compensation: $514.2K
Chief Medical Officer
Total Annual Compensation: $308.5K
Senior Vice President, General Counsel and Co...
Total Annual Compensation: $277.3K
Chief Compliance Officer
Total Annual Compensation: $270.6K
Compensation as of Fiscal Year 2013.

amedisys inc (AMED) Key Developments

Amedisys Announces Completion of SEC Investigation

Amedisys Inc. announced that it has been advised by the staff of the Securities and Exchange Commission (SEC) that the investigation by the SEC related to the company's operations and participation in the Medicare program has been completed and that the staff does not intend to recommend any enforcement action by the SEC. The company had previously reported the existence of this investigation in June 2010.

Amedisys, Inc. Provides Earnings Guidance for the Second Quarter Ending June 30, 2014 and for the Full Year of 2014

Amedisys Inc. provided earnings guidance for the second quarter ending June 30, 2014 and for the full year of 2014. For the quarter, the company anticipates revenue in the range of $300 million -$305 million, and adjusted earnings per share from continuing operations of between $0.15 and $0.20. While these results represent a significant improvement from the first quarter, the company remains cautious on full-year outlook due to the seasonality of the business and the early-stage nature of some of the performance initiatives undertaken thus far in 2014.

Amedisys Inc. Presents at Jefferies 2014 Global Healthcare Conference, Jun-02-2014 09:00 AM

Amedisys Inc. Presents at Jefferies 2014 Global Healthcare Conference, Jun-02-2014 09:00 AM. Venue: Grand Hyatt, New York, New York, United States. Speakers: Dale E. Redman, Interim Chief Financial Officer, Ronald A. LaBorde, Interim Chief Executive Officer, President and Director.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMED:US $15.69 USD -0.22

AMED Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Almost Family Inc $23.77 USD +0.27
BioScrip Inc $7.35 USD -0.08
Chemed Corp $95.10 USD +0.73
Gentiva Health Services Inc $15.60 USD +0.15
LHC Group Inc $22.45 USD +0.21
View Industry Companies
 

Industry Analysis

AMED

Industry Average

Valuation AMED Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.4x
Price/Book 1.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMEDISYS INC, please visit www.amedisys.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.